lansoprazole (Prevacid)

629  relevant articles (144 outcomes, 161 trials/studies) found for this Drug

Prevacid; 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole; AG 1749; AG-1749; Abbot Brand of Lansoprazole; Agopton; Almirall Brand of Lansoprazole; Bamalite; Hoechst Brand of Lansoprazole; Hormona Brand of Lansoprazole; Lanzor; Lederle Brand of Lansoprazole; Monolitum; Ogast; Ogastro; Opiren; Prezal; Pro Ulco; Promeco; Promeco Brand of Lansoprazole; Salvar Brand of Lansoprazole; TAK 390MR; TAK-390MR; TAK390MR; TAP Brand of Lansoprazole; Takeda Brand of Lansoprazole; Takepron; Tecnobio Brand of Lansoprazole; Ulpax; Vinas Brand of Lansoprazole; Wyeth Brand of Lansoprazole; Zoton; dexlansoprazole; lanzoprazole

Relationship Network

Drug Context: Research Results

Experts

1.	Huang, Bidan: 7 articles (01/2007 - 01/2002)
2.	Lai, K C: 6 articles (02/2006 - 06/2001)
3.	Wong, W M: 6 articles (02/2006 - 06/2001)
4.	Lam, S K: 6 articles (02/2004 - 02/2000)
5.	De Micheli, E: 5 articles (02/2006 - 01/2002)
6.	Frazzoni, M: 5 articles (02/2006 - 01/2002)
7.	Wong, B C Y: 5 articles (02/2006 - 10/2002)
8.	Savarino, V: 4 articles (02/2006 - 01/2002)
9.	Chan, C K: 4 articles (02/2006 - 06/2001)
10.	Tolia, Vasundhara: 4 articles (03/2005 - 01/2002)

Related Diseases

1.	Duodenal Ulcer (Curling's Ulcer) 08/10/1998 - "CONCLUSIONS: In patients with an active or a recent history of duodenal ulcer, lansoprazole-based triple therapy for 10 or 14 days is highly effective in the eradication of H pylori. " 04/01/1998 - "CONCLUSIONS: In patients with active or a recent history of duodenal ulcer, a 14-day course of lansoprazole-based triple therapy without additional acid suppression therapy is highly effective in the eradication of H. " 10/01/1996 - "CONCLUSIONS: Lansoprazole was effective for prompt symptom relief in most patients and was able to heal more than 90% of gastric and duodenal ulcers with minimal side effects." 10/01/1995 - "CONCLUSION: Lansoprazole is an effective and safe treatment for duodenal ulcer and the 15 mg dose is as effective as 30 or 60 mg." 09/01/1995 - "It is shown that lansoprazole is effective and safe for treatment of duodenal ulcer." Order ALL the reference details at left...
2.	Gastroesophageal Reflux (GERD) 09/01/2005 - "CONCLUSIONS: Step-down lansoprazole therapy is considered very effective in terms of rapid effect, long-term effect and high quality GERD treatment." 02/15/2004 - "CONCLUSION: Lansoprazole dosages of 30 mg and 15 mg once daily provide a satisfactory decrease for oesophageal acid exposure and are equally effective for the treatment of gastro-oesophageal reflux disease in the Chinese population." 03/01/2008 - "The objective of this study was to assess the clinical efficacy of 2 dosing regimens of lansoprazole in infants with GERD using the revised infant gastroesophageal reflux questionnaire scores (I-GERQ-R). " 12/01/2005 - "Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients." 01/01/2002 - "OBJECTIVES: To assess the efficacy of lansoprazole for the relief of symptoms due to gastroesophageal reflux disease (GERD) in children 1 to 11 years of age. " Order ALL the reference details at left...
3.	Ulcer 01/01/1991 - "AG-1749 raised the percentage of time with high pH to 99% from the 68% obtained with an H2RA and cured 88% of this type of ulcer. " 10/15/2003 - "Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial." 07/01/1999 - "RESULTS: Within 1 month of study initiation, 27% (four out of 15) of placebo-treated patients experienced ulcer recurrence as compared to 13% (two out of 15) and 6% (one out of 18) of lansoprazole 15 mg and 30 mg treated patients, respectively. " 01/01/1995 - "In study II, the ulcer contraction rate after 8 weeks of treatment with lansoprazole was 71.8%, significantly higher than that achieved with H2-receptor antagonists. " 01/01/1995 - "The effect of lansoprazole versus an H2-receptor antagonist on the contraction of ulcer echoes (study II) was also investigated. " Order ALL the reference details at left...
4.	Infection 09/01/1996 - "4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection." 09/01/1998 - "Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection." 05/01/1999 - "Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients." 11/01/2004 - "pylori infection, and to study the test performance after patients were treated with lanzoprazole, and after eradication therapy. " 08/01/2001 - "pylori infection, compared with a lansoprazole-based regimen, in a randomized multicentre study. " Order ALL the reference details at left...
5.	Esophagitis 08/01/2009 - "One hundred ninety-five subjects received lansoprazole for <1 to 72 months; most received daily doses of <or=30 mg. Lansoprazole maintained erosive esophagitis remission in 75% of subjects receiving treatment for <or=72 months, with 39 subjects experiencing 50 recurrences. " 03/01/2005 - "RESULTS: Lansoprazole produced a significant reduction from baseline in the median percentage of days with reflux symptoms (91 to 43% in the 64 adolescents with non-erosive disease and 85 to 16% in the 23 adolescents with erosive esophagitis, P < or = 0.001 for each comparison). " 06/01/2002 - "Both regimens significantly reduced esophageal acid exposure time and increased the median 24-h gastric pH. CONCLUSIONS: Both long term lansoprazole regimens are equally effective in preventing the recurrence of esophagitis, independent of the modality of drug administration. " 08/01/2009 - "Long-term lansoprazole is effective and well tolerated when used to maintain erosive esophagitis remission for <or=6 years." 03/01/2005 - "Lansoprazole 30 mg once daily for 8 weeks was effective in healing erosive esophagitis. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Omeprazole (Esomeprazole)
2.	Ranitidine (Zantac)
3.	Amoxicillin (Wymox)
4.	Clarithromycin (Biaxin)
5.	Proton Pumps (Proton Pump)
6.	pantoprazole (Protonix)
7.	Proton Pump Inhibitors
8.	Famotidine (Pepcid)
9.	rabeprazole (Aciphex)
10.	Histamine (Histamine Dihydrochloride)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Fundoplication
3.	Withholding Treatment
4.	Angioplasty (Angioplasties)
5.	Oral Administration